Toggle Offcanvas
...
 
免疫抑制剂招标

免疫抑制剂招标

查看免疫抑制剂招标,RFP和合同。自2002年以来,竞标具有最佳,最全面的招标平台的随时可用的免疫抑制剂招标。 竞标免疫抑制剂招标对于各种规模的公司来说是极其赚钱的。招标当局和私营公司释放了数千份价值数百万的合同,用于采购免疫抑制剂。

全球招标是致力于招标和政府合同的最大平台。全球台人拥有超过20年的招标业务经验,提供了最广泛,最可靠的招标/RFP/合同数据库。该平台汇总了公共和私人资源的合同,与超过50万买家的庞大网络建立了联系。我们细致的过程采用了先进的人工智能,涉及从十万来源收集信息。然后,将数据智能分类为数千个子类别,以方便过滤并以用户友好的格式显示,以快速理解。

除了招标信息外,我们还提供深入的免疫抑制剂市场分析,出价咨询服务以及对顶级投标人和获胜者的见解。 立即注册以立即访问无限制的免疫抑制剂招标,高级搜索过滤器,市场分析,行业趋势,招标培训和24/7客户支持。

20 Live Notices for 免疫抑制剂招标

Showing 1 to 20

Supplies Of Medicinal Products For Drug Programs And Various Drugs
country Poland
posting date28 Nov 2024
deadline30 Dec 2024
Supply Of Medicines With Registration No. 7300011490
country Greece
posting date26 Nov 2024
deadline11 Dec 2024
Supply of RAVULIZUMAB 300MG/3ML INJ
country Oman
posting date26 Nov 2024
deadline02 Dec 2024
Supply of BUPROPION 150 MG XL [ WELLBUTRIN XL ]&USTEKINUMAB 130 MG INJECTION&HEPATITIS B VACCINE 20 MICROGRAM/ML&CITANEST WITH OCTAPRESSIN CARTRIDGES&LAMOTRIGINE-1A PHARMA 50 MG TABLET&EPHEDRINE HYDROCHLORIDE INJ 30 MG&BELATACEPT 250MG INJECTION
country Oman
posting date26 Nov 2024
deadline02 Dec 2024
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
country Poland
posting date22 Nov 2024
deadline23 Dec 2024
Supplies Of Medicinal Products For Drug Programs And Various Drugs
country Poland
posting date20 Nov 2024
deadline24 Dec 2024
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
country Poland
posting date19 Nov 2024
deadline19 Dec 2024
Lp Containing Golimumab 2024
country Czech Republic
posting date08 Nov 2024
deadline12 Dec 2024
Medicinal Preparations Containing Golimumab Ii.
country Czech Republic
posting date06 Nov 2024
deadline09 Dec 2024
Lp Containing Ustekinumab 2024
country Czech Republic
posting date06 Nov 2024
deadline11 Dec 2024
Lp Containing Arsenic Oxide 2024
country Czech Republic
posting date06 Nov 2024
deadline11 Dec 2024
Supply Of Medicinal Products And Medical Devices.
country Poland
posting date05 Nov 2024
deadline11 Dec 2024
Supplies Of Medicines – Medicinal Substance Etanercept – Atc L04Ab01
country Czech Republic
posting date05 Nov 2024
deadline04 Dec 2024
Medicinal Products Containing Cladribine And Baricitinib
country Czech Republic
posting date04 Nov 2024
deadline02 Dec 2024
The Medicine Ravulizumab
country Lithuania
posting date15 Oct 2024
deadline15 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Abatacept (Atc Code: L04Aa24).
country Germany
posting date10 Nov 2023
deadline27 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Certolizumab Pegol (Atc Code: L04Ab05).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fingolimod (Atc Code: L04Aa27).
country Germany
posting date14 Aug 2023
deadline28 Jul 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Infliximab (Atc Code: L04Ab02).
country Germany
posting date09 Jun 2023
deadline27 May 2025

Share Share this page